This international meeting is a fantastic opportunity to gather for three days and share many updated aspects concerning the use of liquid biopsies in cancer patients. Moreover, this meeting covers many new developments of liquid biopsy for clinical implementation, with some specific focuses on the role of liquid biopsy in treatment decision making both for immuno-oncology and targeted therapies. Moreover, special sessions will be dedicated to the new aspects of minimal residual disease detection, early detection and screening cancers, and monitoring disease by blood sampling for tracking resistance mechanisms to different therapeutic.
Special support will be offered to young scientists and clinicians who will be working alongside renowned scientists (e.g., oral presentations selected on the basis of abstracts from keynote lectures); a unique opportunity for the new generation!
The President of the AACR and the President of ESMO will be present among all the international experts in liquid biopsy.
This event is supported by INCa, the Fondation ARC pour la Recherche sur le Cancer, and the Ligue contre le Cancer.*
